Stefano Palea, Moèz Rekik, Céline Rouget, Philippe Camparo, Henri Botto, Pascal Rischmann, Philippe Lluel, Timothy D Westfall
Index: Eur. J. Pharmacol. 690(1-3) , 202-6, (2012)
Full Text: HTML
Fenoterol has been reported to be a potent and selective β(2)-adrenoceptor agonist and is currently used clinically to treat asthma. Electrical field stimulation (EFS) of isolated urinary bladder mimics the voiding contraction by stimulating parasympathetic nerves, resulting in neurogenic contractions. To determine if stimulation of β(2)-adrenoceptors can inhibit this response, fenoterol was tested against EFS-induced contractions in human isolated urinary bladder and compared with mouse and rat. Bladder strips were mounted in organ baths and reproducible contractions induced by EFS. Fenoterol was added cumulatively in the presence of the β(2)-adrenoceptor antagonist ICI118551 or the β(3)-adrenoceptor antagonist L-748337. Fenoterol inhibited neurogenic contractions in all three species in a concentration-dependent manner with pEC(50) values of 6.66 ± 0.11, 6.86 ± 0.06 and 5.71 ± 0.1 in human, mouse and rat respectively. In human bladder strips ICI118551 (100 nM) did not affect responses to fenoterol, while L-748337 (0.3-3 μM) produced rightward shifts of the concentration-response curves with a pA(2) value of 8.10. In mouse bladder strips ICI118551 (30 nM) blocked the inhibitory effect of fenoterol (pA(2)=8.80), while L-748337 (10 μM) inhibited the response with a pA(2) of 5.79. In rat bladder ICI118551 (30 nM) was without effect, while L-748,337 (10 μM) inhibited the response to fenoterol with a pA(2) of 5.40. From these results it is clear that fenoterol potently activates β(3)-adrenoceptors in human isolated urinary bladder to inhibit EFS-induced contractions. Fenoterol also activates β(3)-adrenoceptors in rat, but β(2)-adrenoceptors in mouse bladder to inhibit EFS-induced contractions.Copyright © 2012 Elsevier B.V. All rights reserved.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Fenoterol hydrobromide
CAS:1944-12-3 |
C17H22BrNO4 |
Inhaled Pharmacotherapy and Stroke Risk in Patients with Chr...
2015-01-01 [PLoS ONE 10 , e0130102, (2015)] |
[Mechanism of the slow inotropic response of the mouse atriu...
2011-11-01 [Ross. Fiziol. Zh. Im. I. M. Sechenova 97(11) , 1223-36, (2011)] |
Contribution of the extracellular cAMP-adenosine pathway to ...
2012-06-01 [J. Pharmacol. Exp. Ther. 341(3) , 820-8, (2012)] |
Isolation and characterization of human primary enterocytes ...
2012-11-01 [Scand. J. Gastroenterol. 47(11) , 1334-43, (2012)] |
Cannabinoid receptor activation correlates with the proapopt...
2012-10-01 [J. Pharmacol. Exp. Ther. 343(1) , 157-66, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved